Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 8719 | 5.25 |
09:34 ET | 2124 | 5.325 |
09:36 ET | 2319 | 5.47 |
09:38 ET | 2168 | 5.5 |
09:39 ET | 6164 | 5.5498 |
09:41 ET | 2216 | 5.615 |
09:43 ET | 2625 | 5.57 |
09:45 ET | 1180 | 5.61 |
09:48 ET | 6438 | 5.67 |
09:50 ET | 2133 | 5.65 |
09:52 ET | 949 | 5.675 |
09:54 ET | 3353 | 5.69 |
09:56 ET | 1832 | 5.71 |
09:57 ET | 1200 | 5.7 |
09:59 ET | 1400 | 5.68 |
10:01 ET | 2827 | 5.69 |
10:03 ET | 1555 | 5.73 |
10:06 ET | 9099 | 5.745 |
10:08 ET | 2811 | 5.76 |
10:10 ET | 2315 | 5.73 |
10:12 ET | 2187 | 5.675 |
10:14 ET | 400 | 5.66 |
10:15 ET | 3533 | 5.65 |
10:17 ET | 800 | 5.66 |
10:19 ET | 831 | 5.66 |
10:21 ET | 1824 | 5.67 |
10:24 ET | 3364 | 5.635 |
10:26 ET | 2298 | 5.61 |
10:28 ET | 1001 | 5.63 |
10:30 ET | 1544 | 5.64 |
10:32 ET | 3370 | 5.68 |
10:33 ET | 2889 | 5.66 |
10:35 ET | 300 | 5.65 |
10:37 ET | 3161 | 5.67 |
10:39 ET | 1191 | 5.67 |
10:42 ET | 2310 | 5.69 |
10:44 ET | 1600 | 5.73 |
10:46 ET | 1750 | 5.71 |
10:48 ET | 2379 | 5.71 |
10:50 ET | 5160 | 5.66 |
10:51 ET | 2673 | 5.65 |
10:53 ET | 800 | 5.64 |
10:55 ET | 600 | 5.66 |
10:57 ET | 4451 | 5.7 |
11:00 ET | 6119 | 5.7299 |
11:02 ET | 2200 | 5.79 |
11:04 ET | 1600 | 5.78 |
11:06 ET | 3570 | 5.76 |
11:08 ET | 2139 | 5.78 |
11:09 ET | 918 | 5.82 |
11:11 ET | 1338 | 5.815 |
11:13 ET | 1868 | 5.86 |
11:15 ET | 2233 | 5.86 |
11:18 ET | 4061 | 5.85 |
11:20 ET | 5594 | 5.835 |
11:22 ET | 1848 | 5.8238 |
11:24 ET | 3092 | 5.88 |
11:26 ET | 6349 | 5.83 |
11:27 ET | 400 | 5.83 |
11:29 ET | 3562 | 5.86 |
11:31 ET | 6813 | 5.77 |
11:36 ET | 1150 | 5.77 |
11:38 ET | 1204 | 5.74 |
11:40 ET | 1850 | 5.71 |
11:44 ET | 5589 | 5.7 |
11:47 ET | 3296 | 5.69 |
11:49 ET | 750 | 5.69 |
11:51 ET | 1874 | 5.68 |
11:54 ET | 8000 | 5.73 |
11:56 ET | 6835 | 5.745 |
11:58 ET | 1992 | 5.76 |
12:00 ET | 12881 | 5.77 |
12:02 ET | 5487 | 5.85 |
12:03 ET | 1300 | 5.8 |
12:05 ET | 2689 | 5.8 |
12:07 ET | 4645 | 5.78 |
12:09 ET | 1090 | 5.77 |
12:12 ET | 300 | 5.775 |
12:14 ET | 2527 | 5.78 |
12:16 ET | 291 | 5.79 |
12:18 ET | 1065 | 5.785 |
12:20 ET | 100 | 5.785 |
12:21 ET | 900 | 5.785 |
12:23 ET | 7732 | 5.7 |
12:25 ET | 250 | 5.72 |
12:30 ET | 900 | 5.72 |
12:32 ET | 2267 | 5.6 |
12:36 ET | 3726 | 5.595 |
12:38 ET | 7358 | 5.595 |
12:39 ET | 1200 | 5.605 |
12:41 ET | 500 | 5.605 |
12:43 ET | 1639 | 5.58 |
12:45 ET | 100 | 5.58 |
12:48 ET | 432 | 5.58 |
12:50 ET | 1524 | 5.58 |
12:52 ET | 3864 | 5.56 |
12:54 ET | 2128 | 5.55 |
12:56 ET | 1000 | 5.59 |
12:57 ET | 2313 | 5.58 |
12:59 ET | 3700 | 5.58 |
01:01 ET | 1125 | 5.58 |
01:03 ET | 600 | 5.59 |
01:06 ET | 1441 | 5.58 |
01:08 ET | 400 | 5.59 |
01:10 ET | 2237 | 5.6 |
01:12 ET | 2461 | 5.56 |
01:14 ET | 983 | 5.57 |
01:15 ET | 2777 | 5.5693 |
01:17 ET | 1207 | 5.58 |
01:19 ET | 2349 | 5.6 |
01:21 ET | 1276 | 5.61 |
01:24 ET | 2859 | 5.6 |
01:26 ET | 400 | 5.59 |
01:28 ET | 603 | 5.59 |
01:30 ET | 2321 | 5.58 |
01:32 ET | 1906 | 5.59 |
01:33 ET | 1600 | 5.58 |
01:35 ET | 300 | 5.55 |
01:37 ET | 1400 | 5.54 |
01:39 ET | 1061 | 5.545 |
01:42 ET | 1980 | 5.54 |
01:44 ET | 1232 | 5.55 |
01:46 ET | 681 | 5.56 |
01:48 ET | 300 | 5.58 |
01:50 ET | 2640 | 5.575 |
01:51 ET | 2318 | 5.55 |
01:53 ET | 100 | 5.55 |
01:55 ET | 200 | 5.55 |
01:57 ET | 2946 | 5.5338 |
02:00 ET | 1000 | 5.53 |
02:02 ET | 1162 | 5.55 |
02:06 ET | 1357 | 5.56 |
02:08 ET | 2065 | 5.545 |
02:09 ET | 798 | 5.53 |
02:11 ET | 100 | 5.53 |
02:13 ET | 600 | 5.53 |
02:18 ET | 1397 | 5.52 |
02:20 ET | 400 | 5.52 |
02:22 ET | 490 | 5.53 |
02:24 ET | 1753 | 5.51 |
02:26 ET | 100 | 5.5 |
02:27 ET | 300 | 5.505 |
02:29 ET | 453 | 5.505 |
02:31 ET | 1700 | 5.505 |
02:33 ET | 6414 | 5.52 |
02:36 ET | 1358 | 5.505 |
02:38 ET | 500 | 5.49 |
02:40 ET | 1445 | 5.49 |
02:42 ET | 1404 | 5.51 |
02:44 ET | 5142 | 5.52 |
02:45 ET | 300 | 5.525 |
02:47 ET | 1459 | 5.51 |
02:49 ET | 1161 | 5.52 |
02:51 ET | 1300 | 5.51 |
02:54 ET | 1600 | 5.51 |
02:56 ET | 100 | 5.5 |
02:58 ET | 300 | 5.52 |
03:00 ET | 1212 | 5.515 |
03:02 ET | 599 | 5.51 |
03:03 ET | 1555 | 5.53 |
03:05 ET | 3538 | 5.52 |
03:07 ET | 300 | 5.49 |
03:09 ET | 1910 | 5.49 |
03:12 ET | 300 | 5.495 |
03:14 ET | 4430 | 5.47 |
03:16 ET | 450 | 5.475 |
03:18 ET | 400 | 5.48 |
03:20 ET | 2489 | 5.465 |
03:21 ET | 5410 | 5.48 |
03:23 ET | 1538 | 5.465 |
03:25 ET | 1050 | 5.465 |
03:27 ET | 100 | 5.46 |
03:30 ET | 8221 | 5.435 |
03:32 ET | 1766 | 5.415 |
03:34 ET | 334 | 5.42 |
03:36 ET | 700 | 5.41 |
03:38 ET | 14459 | 5.455 |
03:39 ET | 8128 | 5.48 |
03:41 ET | 3131 | 5.465 |
03:43 ET | 4119 | 5.46 |
03:45 ET | 2082 | 5.435 |
03:48 ET | 1266 | 5.435 |
03:50 ET | 6491 | 5.445 |
03:52 ET | 6764 | 5.425 |
03:54 ET | 6038 | 5.435 |
03:56 ET | 18154 | 5.425 |
03:57 ET | 16972 | 5.41 |
03:59 ET | 49411 | 5.44 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 323.7M | -1.7x | --- |
Fractyl Health Inc | 322.8M | -3.9x | --- |
Alto Neuroscience Inc | 321.5M | -5.8x | --- |
Skye Bioscience Inc | 325.9M | -2.7x | --- |
Solid Biosciences Inc | 317.0M | -2.1x | --- |
Tenaya Therapeutics Inc | 330.6M | -2.4x | --- |
Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $323.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.16 |
EPS | $-3.24 |
Book Value | $6.10 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.